| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/23/2009 | WO2009091291A1 N-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydro-5h-pyrimidinesulfone)-isonicotinoyl hydrazide silver salt |
| 07/23/2009 | WO2009090679A1 Use of acyclovir for the treatment of condylomatosis |
| 07/23/2009 | WO2009090330A2 Use of protein 8c2 for in vitro diagnosis of mycoplasma pneumoniae infections |
| 07/23/2009 | WO2009090222A1 Naphthyridin-2(1h) -one compounds useful as antibacterials |
| 07/23/2009 | WO2009090168A1 Anti-bacterial compositions |
| 07/23/2009 | WO2009090063A1 Steroid sapogenin, androstane and triterpenoid sapogenin derivatives for the treatment and prevention of infectious diseases |
| 07/23/2009 | WO2009089822A2 Use of an acetylsalicylic acid salt for the treatment of viral infections |
| 07/23/2009 | WO2009089702A1 Stable 6-methoxy-2',3'-dideoxyguanosine, method for preparing the same and pharmaceutical composition containing the same |
| 07/23/2009 | WO2009089659A1 Pyrollidine-based compounds |
| 07/23/2009 | WO2009061889A3 Grape polyphenolics for platelet and bacterial control |
| 07/23/2009 | WO2009053535A3 Peptide vaccine for influenza virus |
| 07/23/2009 | WO2009046845A3 Use of a lactoferrin partial peptide peptide as a therapeutic agent |
| 07/23/2009 | WO2009043523A3 Cortistatin 17 and neuropeptide 1 for use as therapeutic agent |
| 07/23/2009 | WO2009040084A3 Use of a peptide as a therapeutic agent |
| 07/23/2009 | WO2009040034A3 Use of a peptide as a therapeutic agent |
| 07/23/2009 | WO2009039973A3 Use of peptide arg-asn-ile-ala-glu-ile-ile-lys-asp-ile-oh or its combination with the peptide asp-arg-gly-asp-ser-oh as a therapeutic agent |
| 07/23/2009 | WO2009039971A3 Use of the peptide sfllr-oh and muramyl dipeptide as therapeutic agents |
| 07/23/2009 | WO2009037262A3 Method of preventing early lawsonia intracellularis infections |
| 07/23/2009 | WO2009033816A3 Use of the combination of thymosin beta 10 and thymosin alpha 1 peptides as a therapeutic agent |
| 07/23/2009 | WO2009033773A3 Use endothelin 2, alone or combined with a nonapeptide, a peptide as a therapeutic agent |
| 07/23/2009 | WO2009033761A3 Use of a fragment of hcv nucleo protein, alone or together with endothelin-3, as a therapeutic agent |
| 07/23/2009 | WO2009011912A8 A composition for treating hiv comprising virus-like particles |
| 07/23/2009 | WO2009005338A3 Solid forms ult-i, ult-2 and ult-3 of emtricitabine |
| 07/23/2009 | WO2008151639A3 Oligonucleotides for modulation of target rna activity |
| 07/23/2009 | WO2008133684A8 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 07/23/2009 | WO2008127179A8 Fusion protein vaccine |
| 07/23/2009 | WO2008096001A8 Hcv inhibiting macrocyclic phenylcarbamates |
| 07/23/2009 | WO2008084504A3 Pharmaceutical compositions of angiotensin ii receptor blockers |
| 07/23/2009 | WO2008068631A8 Vaccines including antigen from four strains of influenza virus |
| 07/23/2009 | WO2008056388A8 Drug based on ozonized terpenes or terpene-derivatives, processes for producing it and uses thereof |
| 07/23/2009 | WO2007133153A8 Improved antimicrobial peptides |
| 07/23/2009 | WO2007125142A8 Antimicrobial linear peptides |
| 07/23/2009 | WO2007091958A8 Novel antimicrobial peptides and use thereof |
| 07/23/2009 | US20090187021 Indane compounds as ccr5 antagonists |
| 07/23/2009 | US20090186933 Indole, azaindole and related heterocyclic pyrrolidine derivatives |
| 07/23/2009 | US20090186912 Anti-infective agents and uses thereof |
| 07/23/2009 | US20090186906 N-((S)-4,4-dimethyl-1-oxo-1-((3aS,6aR)-3-oxo-dihydro-2H-furo[3,2-b]pyrrol-4(5H6H, 6aH)-yl)pentan-2-yl)-4-(4-methylpiperazin-1-yl)benzamide; treatment of a disease selected from osteoporosis, Paget's disease, Chagas's disease, malaria, gingival diseases, hypercalaemia, metabolic bone disease, bone cancer |
| 07/23/2009 | US20090186883 Stable Aqueous Suspension |
| 07/23/2009 | US20090186865 Lyophilization Process |
| 07/23/2009 | US20090186856 Micronutrient phosphates as dietary and health supplements |
| 07/23/2009 | US20090186852 Tri- and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens |
| 07/23/2009 | US20090186846 Methods to reprogram splice site selection in pre-messenger RNAs |
| 07/23/2009 | US20090186842 Methods and compositions for inhibition of viral replication |
| 07/23/2009 | US20090186841 Novel aminoglycoside antibiotics |
| 07/23/2009 | US20090186838 Amphotericin Derivatives |
| 07/23/2009 | US20090186833 Method for producing pectin hydrolysis products |
| 07/23/2009 | US20090186830 Macrocycles and their uses |
| 07/23/2009 | US20090186821 Use of aspartic proteases in cosmetics and therapeutics |
| 07/23/2009 | US20090186820 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 07/23/2009 | US20090186111 Novel Bacteria and Pharmaceutically Active Products Obtained Therefrom |
| 07/23/2009 | US20090186104 Herbal compositions for the treatment of mucosal lesions |
| 07/23/2009 | US20090186101 Use of Elderberry Extract |
| 07/23/2009 | US20090186099 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 07/23/2009 | US20090186064 Antimicrobial material and method for making the same |
| 07/23/2009 | US20090186057 Topical Use of Probiotic Bacillus Spores to Prevent or Control Microbial Infections |
| 07/23/2009 | US20090186056 Compositions and methods for preventing infection |
| 07/23/2009 | US20090186050 Live attenuated metapneumovirus strains and their use in vaccine formulations and chimeric metapneumovirus strains |
| 07/23/2009 | US20090186045 Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants |
| 07/23/2009 | US20090186043 Method and compositions for preventing and treating streptococcus pneumoniae infection |
| 07/23/2009 | US20090186039 Novel use of grp 94 in virus infection |
| 07/23/2009 | US20090186035 Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| 07/23/2009 | US20090186030 Antibodies that bind both bcma and taci |
| 07/23/2009 | US20090186028 Detection of mutations in a gene associated with resistance to viral infection |
| 07/23/2009 | US20090186012 Plant extract |
| 07/23/2009 | DE102008005493A1 4-(Pyrrolo[2,3-c] pyridine-3-yl)-pyrimidin-2-yl-amin-derivate 4- (pyrrolo [2,3-c] pyridine-3-yl) -pyrimidin-2-yl-amine derivatives |
| 07/23/2009 | DE102008004386A1 Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen Use of a Acetylsalicylsäuresalzes for treating viral infections |
| 07/23/2009 | CA2714286A1 The use of an acetylsalicylic acid salt for treating viral infections |
| 07/23/2009 | CA2712783A1 Beta-lactamase inhibitors |
| 07/23/2009 | CA2711972A1 Anti-bacterial compositions |
| 07/23/2009 | CA2711912A1 Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents |
| 07/23/2009 | CA2701492A1 Methods of inhibiting viral infection |
| 07/22/2009 | EP2080779A1 Polymeric derivative of nucleic acid metabolic antagonist |
| 07/22/2009 | EP2080771A2 New interferon beta-like molecules |
| 07/22/2009 | EP2080765A1 Phosphonocephem Derivates, Their Production And Use |
| 07/22/2009 | EP2080761A1 Compounds |
| 07/22/2009 | EP2080525A1 Remodeling and Glycoconjugation of Peptides |
| 07/22/2009 | EP2080504A2 Topical composition comprising n-acetylaldosamines or n-acetylamino acids |
| 07/22/2009 | EP2079738A2 7-azaindole derivatives as c-met kinase inhibitors |
| 07/22/2009 | EP2079529A1 Antimicrobially active composition having a content of bispyridinium alkane (octenidine dihydrochloride) |
| 07/22/2009 | EP2079480A2 Hcv ns3 protease inhibitors |
| 07/22/2009 | EP2079477A2 Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses |
| 07/22/2009 | EP2079474A1 Liposome encapsulated poly-iclc method to prophylactically treat an avian influenza viral infection |
| 07/22/2009 | EP2079468A1 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 07/22/2009 | EP2005968A9 Nanocomposite particle |
| 07/22/2009 | EP1646610B1 Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 07/22/2009 | EP1623714A4 Treatment kit which assists with antibiotic therapy for intracellular infectious diseases |
| 07/22/2009 | EP1506008B1 Mucosal vaccines with chitosan adjuvant and/or meningococcal antigens |
| 07/22/2009 | EP1499290B1 Warming and nonirritating lubricant compositions |
| 07/22/2009 | EP1471937B1 A continuous cell line for the production of vaccines |
| 07/22/2009 | EP1432791B1 Alphavirus replicon vector systems |
| 07/22/2009 | EP1392680B1 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3 |
| 07/22/2009 | EP1392241B1 System for osmotic delivery of pharmaceutically active agents |
| 07/22/2009 | EP1357938B1 Hyperblebbing bacterial strains and use thereof for production of vaccines |
| 07/22/2009 | EP1255563B1 Composition of antigen and glycolipid adjuvant sublingual administration |
| 07/22/2009 | CN101486756A Outer surface proteins, their genes, and their use |
| 07/22/2009 | CN100516221C Nucleotide sequences of mutant swine fever viral strin, polypeptides encoded by these squences and use thereof |
| 07/22/2009 | CN100516034C Inhibitors of aspartyl protease |
| 07/22/2009 | CN100516024C Amino-propanol derivatives |
| 07/22/2009 | CN100516018C Double esters |
| 07/22/2009 | CN100515497C Liposomal delivery of vitamin E based compounds |